Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 6/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5100213 | 0.90 | CHRM3 (0.45) | CCR8CHRM3CHRM2SIGMAR1DRD2 | |
| SCHEMBL8565700 | 0.89 | CHRM3 (0.56) | CCR8CHRM3CHRM2SIGMAR1DRD2 | |
| SCHEMBL8571599 | 0.88 | CHRM3 (0.46) | CCR8CHRM3CHRM2SIGMAR1DRD2 | |
| SCHEMBL5113815 | 0.86 | FAAH (0.47) | CCR8CHRM3CHRM2SIGMAR1DRD2 | |
| Afacifenacin SCHEMBL12229302 | 0.85 | CHRM3 (0.58) | CCR8CHRM3CHRM2DRD2DRD4 | |
| Afacifenacin SCHEMBL1192029 | 0.85 | CHRM3 (0.58) | CCR8CHRM3CHRM2DRD2DRD4 | |
| Afacifenacin SCHEMBL29537778 | 0.85 | CHRM3 (0.58) | CCR8CHRM3CHRM2DRD2DRD4 | |
| SCHEMBL29445321 | 0.85 | OPRL1 (0.52) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL6168606 | 0.85 | OPRL1 (0.52) | CHRM3CHRM2DRD2DRD4OPRM1 | |
| SCHEMBL8562694 | 0.84 | KDM1A (0.56) | SIGMAR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0626373-B1 | Quinazolinone derivatives | SUMITOMO PHARMA (JP) | 1998-12-23 | — | — | EP | disclosed |
| US-5556860-A | ANTIISCHEMIC AGENTS, BRAIN DISORDERS AND BLOOD METAL CONCENTRATIONS AND KIDNEY DISEASE | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0626373-A1 | Quinazolinone derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1994-11-30 | — | — | EP | disclosed |